Image source: Getty ImagesOn November 3, 2025, Florin Court Capital LLP disclosed a new position in iShares Biotechnology ETF (IBB 1.64%), acquiring 77,000 shares in a trade valued at approximately $11.1 million.Acquired 77,000 shares, valued at $11.1 millionTransaction represents 8.7% of 13F reportable AUMPost-trade position: 77,000 shares valued at $11.1 millionIBB is now the fund’s 2nd-largest holding, accounting for 8.7% of AUMWhat happenedAccording to a SEC filing dated November 3, 2025, Florin Court C ...

We recently published Trending Analyst Calls: 10 Stocks to Buy and Sell. Biotechnology ETF (NASDAQ:IBB) is one of the trending analyst calls. Jason Snipe, Founder and CIO of Odyssey Capital Advisors, said in a recent program on CNBC that he’s investing in IBB. Here’s why: “But this is a subsector that’s been under the mat for quite some time. So it’s nice to see some price action there. So couple things for me. I think one, big pharma, they really need to rebuild their pipeline. So I think there’s going ...